整合多参数MRI影像组学模型与膀胱影像报告和数据系统评分无创识别膀胱尿路上皮癌HER2状态
回顾性纳入197例膀胱尿路上皮癌患者,随机分为训练组145例和测试组52例,基于多参数MRI提取影像组学特征并计算VI-RADS评分。最优影像组学模型训练组AUC为0.841(95%CI 0.779-0.904)、测试组为0.794(95%CI 0.650-0.938);KNN模型将影像组学特征与VI-RADS评分整合为列线图,训练组AUC为0.889(95%CI 0.840-0.938)、测试组为0.826(95%CI 0.702-0.950)。
要点
- 多参数MRI影像组学模型可无创预测膀胱尿路上皮癌HER2状态,训练组AUC 0.841、测试组AUC 0.794。
- 将影像组学特征与VI-RADS评分整合的列线图预测效能更高,训练组AUC 0.889、测试组AUC 0.826。
- 共197例患者中HER2阳性110例(55.8%)、HER2阴性87例(44.2%),以免疫组化为参考标准。
核心结论
- 基于多参数MRI影像组学与VI-RADS评分整合的预测模型可较准确预测膀胱尿路上皮癌HER2状态,可能有助于临床医生制定个体化治疗策略。
研究设计与样本
- 回顾性研究,共纳入197例膀胱尿路上皮癌患者,随机分为训练组145例和测试组52例,基于多参数MRI提取影像组学特征并评估VI-RADS评分,以免疫组化结果为参考标准,采用LASSO算法和六种机器学习方法筛选特征并构建模型,以受试者工作特征曲线下面积(AUC)评价预测效能。
诊断标准与关键数值
- 共筛选出8个特征构建影像组学标签,最优影像组学标签训练组AUC为0.841(95%CI 0.779-0.904)、测试组AUC为0.794(95%CI 0.650-0.938);选择KNN模型整合影像组学标签与VI-RADS评分构建列线图,训练组AUC为0.889(95%CI 0.840-0.938)、测试组AUC为0.826(95%CI 0.702-0.950)。
临床应用与阅片要点
- 作者认为该模型可能有助于临床医生制定个体化治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: HER2 expression is crucial for the application of HER2-targeted antibody-drug conjugates. This study aims to construct a predictive model by integrating multiparametric magnetic resonance imaging (mpMRI) based multimodal radiomics and the Vesical Imaging-Reporting and Data System (VI-RADS) score for noninvasive identification of HER2 status in bladder urothelial carcinoma (BUC).
METHODS: A total of 197 patients were retrospectively enrolled and randomly divided into a training cohort (n = 145) and a testing cohort (n = 52). The multimodal radiomics features were derived from mpMRI, which were also utilized for VI-RADS score evaluation. LASSO algorithm and six machine learning methods were applied for radiomics feature screening and model construction. The optimal radiomics model was selected to integrate with VI-RADS score to predict HER2 status, which was determined by immunohistochemistry. The performance of predictive model was evaluated by receiver operating characteristic curve with area under the curve (AUC).
RESULTS: Among the enrolled patients, 110 (55.8%) patients were demonstrated with HER2-positive and 87 (44.2%) patients were HER2-negative. Eight features were selected to establish radiomics signature. The optimal radiomics signature achieved the AUC values of 0.841 (95% CI 0.779-0.904) in the training cohort and 0.794 (95%CI 0.650-0.938) in the testing cohort, respectively. The KNN model was selected to evaluate the significance of radiomics signature and VI-RADS score, which were integrated as a predictive nomogram. The AUC values for the nomogram in the training and testing cohorts were 0.889 (95%CI 0.840-0.938) and 0.826 (95%CI 0.702-0.950), respectively.
CONCLUSION: Our study indicated the predictive model based on the integration of mpMRI-based radiomics and VI-RADS score could accurately predict HER2 status in BUC. The model might aid clinicians in tailoring individualized therapeutic strategies.
引用
- Luo C, Li S, Han Y, et al. Noninvasive identification of HER2 status by integrating multiparametric MRI-based radiomics model with the vesical imaging-reporting and data system (VI-RADS) score in bladder urothelial carcinoma. Abdom Radiol (NY). 2025. PMID: 39786584. doi:10.1007/s00261-024-04767-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。